Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro‐osteogenic paracrine response: TERCELOI clinical trial-Reference-Cited by-同舟云学术

Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro‐osteogenic paracrine response: TERCELOI clinical trial

Published:2021-01 Issue:1 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Infante Arantza¹^ORCID,Gener Blanca¹²^ORCID,Vázquez Miguel³,Olivares Nerea⁴,Arrieta Arantza⁴,Grau Gema³,Llano Isabel²^ORCID,Madero Luis⁵^ORCID,Bueno Ana Maria⁶,Sagastizabal Belén⁷,Gerovska Daniela⁸^ORCID,Araúzo‐Bravo Marcos J⁸^ORCID,Astigarraga Itziar³⁹,Rodríguez Clara I.¹^ORCID

Affiliation:

1. Stem Cells and Cell Therapy Laboratory Biocruces Bizkaia Health Research Institute Cruces University Hospital Barakaldo Spain

2. Service of Genetics Cruces University Hospital Barakaldo Spain

3. Department of Pediatrics Biocruces Bizkaia Health Research Institute Cruces University Hospital Barakaldo Spain

4. Department of Biochemistry, Immunology Unit Cruces University Hospital Barakaldo Spain

5. Department of Pediatric Hematology, Oncology and Stem Cells Niño Jesús University Children´s Hospital Madrid Spain

6. Department of Orthopedic Surgery Getafe University Hospital Madrid Spain

7. Department of Endocrinology Getafe University Hospital Madrid Spain

8. Computational Biology and Systems Biomedicine Research Group Biodonostia Health Research Institute Donostia Spain

9. Department of Pediatrics Basque Country University UPV/EHU Leioa Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.265

Reference64 articles.

1. Osteogenesis imperfecta

2. Osteogenesis imperfecta

3. Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia

4. Cole-Carpenter Syndrome Is Caused by a Heterozygous Missense Mutation in P4HB

5. Mutations inSEC24Dcause autosomal recessive osteogenesis imperfecta

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta;Biomedicine & Pharmacotherapy;2024-06

2. Conditioned medium of human mesenchymal stem cells affects stem cell senescence in osteoporosis;Biochemical and Biophysical Research Communications;2024-06

3. Successful transport across continents of GMP-manufactured and cryopreserved culture-expanded human fetal liver-derived mesenchymal stem cells for use in a clinical trial;Regenerative Therapy;2024-06

4. An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol;BMJ Open;2024-06

5. Medical Management for Fracture Prevention in Children with Osteogenesis Imperfecta;Calcified Tissue International;2024-03-29